2 T2D can cause serious complications, including neuropathy, retinopathy, nephropathy (kidney damage), and cardiovascular disease

The Decision Framework A simple framework for the GLOW vs KLOW decision: Choose GLOW if: Your research focuses on the three GLOW pathways without specific anti-inflammatory consideration Cost optimization is a priority You're maintaining consistency with existing GLOW-based protocols The simpler three-peptide framework better matches your research question Choose KLOW if: Your research includes anti-inflammatory mechanism considerations Comprehensive four-pathway mechanism coverage is the priority You're studying skin or tissue research with inflammatory components You're building research on the most current combination peptide logic Inflammatory tissue research is part of the research question Either choice maintains: Same manufacturing approach (SPPS) Same quality framework (Janoshik third-party testing, 99% HPLC purity) Same storage and reconstitution requirements Same Canadian-domestic supply Same research-use-only framework Frequently Asked Questions What's the difference between KLOW and GLOW

It plays a crucial role in protecting cells from oxidative stress, which can lead to premature aging and other skin concerns
Hair quality improvements are more commonly observed after the second cycle
This process helps burn fat more efficiently, making it a popular choice for people looking to lose weight faster while maintaining muscle mass
1 In veterinary medicine, it can be used as an adjunctive treatment for canine dilated cardiomyopathy, with 90% of dogs suffering from this disease showing symptoms of carnitine deficiency